Beam Therapeutics Inc. 8-K

What Happened
Beam Therapeutics Inc. filed a Form 8-K (Item 5.02) reporting that director Carole Ho submitted her resignation notice on January 31, 2026, and will step down from the company’s Board of Directors effective February 27, 2026. The company stated Dr. Ho’s decision was not due to any disagreement with the company’s operations, policies, or practices. The Form 8-K was signed by CEO John Evans and filed on February 5, 2026.

Key Details

• Carole Ho provided notice of resignation on January 31, 2026.
• Resignation effective date: February 27, 2026.
• The company disclosed the resignation did not result from any disagreement with Beam on operations, policies, or practices.
• Disclosure filed via Form 8-K (Item 5.02) and signed by CEO John Evans on February 5, 2026.

Why It Matters
Board changes are material governance events for investors because they can affect oversight, strategy and committee composition. This filing confirms the timing and that the departure was not related to a dispute with management, which may lessen immediate governance concerns. Investors should watch for any follow-up filings about a replacement director or changes to board committees.